Sort
50,496 grants matching “lung cancer”
A systematic approach to uncover the basic mechanisms of checkpoint inhibitor immune related adverse events
$715,543Adam Mor · Columbia University Health Sciences · R01 · FY2025 · AI
Clinical trials employing cancer vaccine combination therapies
$715,531James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Functional Genomics of Chemical-Induced Acute Lung Injury
$715,517George Douglas Leikauf · University Of Pittsburgh At Pittsburgh · U01 · FY2014 · ES
Role of IKK alpha in lung cancer development
$715,207Yinling Hu · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Quantitative Radiomics System Decoding the Tumor Phenotype
$715,149Hugo Aerts · Dana-Farber Cancer Inst · U24 · FY2015 · CA
Monitoring Response to Targeted Therapy in Non-Small Cell Lung Cancer Using 18F..
$715,129Sanjiv S Gambhir · Stanford University · P50 · FY2011 · CA
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
$715,091Roy S Herbst · Yale University · P50 · FY2016 · CA
Novel Incidental Calcium Evaluation (NICE)
$715,062Fatima Rodriguez · Stanford University · R01 · FY2024 · HL
Characterizing the theranostic potential of DLL3-targeting agents in high-grade neuroendocrine carcinomas of the lung and prostate
$715,058Lisa Bodei · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
$714,896Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
$714,894Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
Clinical Implications, Genomics, and Transcriptions of Mucus Plugging in Smokers
$714,886Alejandro Diaz · Brigham And Women'S Hospital · R01 · FY2020 · HL
Methods for Epidemiology Studies
$714,877Paul Albert · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Whole Mouse Cryo-Imaging
$714,793David L Wilson · Bioinvision, Inc. · R42 · FY2008 · CA
The Tumor Suppressor Role of SMARCA4 in SCCOHT
$714,783Bernard E. Weissman · Univ Of North Carolina Chapel Hill · R01 · FY2018 · CA
Tissue Array Research Program
$714,730Stephen Hewitt · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
Empathic Communication Skills Training to Reduce Lung Cancer Stigma
$714,650Smita Banerjee · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
Genomics
$714,644Agnes Viale · Sloan-Kettering Inst Can Research · P30 · FY2017 · CA
Understanding the role of structural racism on racial/ethnic inequities in lung cancer risk
$714,588Iona C Cheng · University Of California, San Francisco · R01 · FY2022 · CA
Instant and reversible wet tissue adhesive tape
$714,479Yuhan Lee · Brigham And Women'S Hospital · R01 · FY2025 · EB
Improved Cardiovascular Risk Reduction to Enhance Rural Primary Care:I-CARE
$714,473Barry L Carter · University Of Iowa · R01 · FY2015 · HL
Therapeutic targeting MDSC-mediated immune suppression in cancer
$714,368Yulia Nefedova · Wistar Institute · R01 · FY2022 · CA
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
$714,336Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Development of New Casein Kinase 1 Inhibitor for the Treatment of Brain Cancers
$714,336Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Optimizing Treatment of Lung Cancer Patients with Comorbidities
$714,307Juan P Wisnivesky · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA